# IntelliProve

> Computer-vision-based physiological estimates from ordinary cameras for digital health platforms.

## Why it is interesting

A reported €2.7M Seed led by Miles Ahead funds clinical validation and potential robotics integrations. The critical question is blood-pressure and heart-rate measurement reliability outside controlled settings, not the fundraising itself.

## Profile

- **Latest funding:** Seed — €2.7M (November 19, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** seed
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-20
- **Latest funding investors:** Miles Ahead, Wit-Gele Kruis, imec.istart

## Funding history

- Seed · €2.7M · November 19, 2026
  Source: https://www.eu-startups.com/2026/11/ghent-based-intelliprove-raises-e2-7-million-to-monitor-vital-signs-with-a-30-second-face-scan-using-any-camera/
- Earlier financing (series undisclosed) · €1.25M · January 20, 2025
  Source: https://intelliprove.com/article/intelliprove-secures-1-25m-to-revolutionize-health-monitoring-tech

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 20, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/intelliprove-camera-vital-signs
